Preferred Label : glyburide;

MeSH definition : An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.; An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide;

MeSH synonym : glybenclamide; Glibenclamide;

MeSH hyponym : diabeta; euglucon 5; HB-419; neogluconin; HB-420; daonil; maninil; micronase; euglucon N; HB 419; HB419; HB 420; HB420;

MeSH CAS label : benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-;

MeSH Related Number : 10238-21-8 (Glyburide);

Registry Number MeSH : 10238-21-8;

Wikipedia link : https://en.wikipedia.org/wiki/Glibenclamide;

Codes EINECS : 233-570-6;

Is substance : O;

UNII : SX6K58TVWC;

InChIKey : ZNNLBTZKUZBEKO-UHFFFAOYSA-N;

Details


Main resources

You can consult :

An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide

https://www.has-sante.fr/jcms/p_3512099/fr/amglidia-glibenclamide-diabete-sucre-neonatal
2024
false
false
false
France
Neonatal Diabetes Mellitus
infant
infant, newborn
child
evaluation of the transparency committee
Glyburide
glyburide

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1298
2019
false
false
false
Canada
infant, newborn
glyburide
administration, oral
injections, subcutaneous
pregnancy
infant, newborn, diseases
hypoglycemic agents
journal article
diabetes complications
insulin
diabetes, gestational

---
https://www.has-sante.fr/portail/jcms/c_2904837/fr/amglidia
https://www.has-sante.fr/portail/jcms/c_2904837/fr/amglidia-glibenclamide-antidiabetique
2019
false
false
false
France
French
orphan drug production
child
treatment outcome
administration, oral
Oral Suspension Dosage Form
hypoglycemic agents
diabetes mellitus
glibenclamide
infant, newborn
infant
Neonatal diabetes mellitus
diabetes mellitus
katp channels
insulin-secreting cells
6q24-Related transient neonatal diabetes mellitus
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
glyburide

---
https://www.ema.europa.eu/medicines/human/EPAR/Amglidia
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
glyburide
drug approval
europe
orphan drug production
child
treatment outcome
administration, oral
Oral Suspension Dosage Form
hypoglycemic agents
hypoglycemic agents
diabetes mellitus
glibenclamide
infant, newborn
infant
Neonatal diabetes mellitus
diabetes mellitus
mutation
drug interactions
katp channels
insulin-secreting cells
6q24-Related transient neonatal diabetes mellitus
drug evaluation, preclinical
glyburide

---
https://www.has-sante.fr/portail/jcms/c_2831681/fr/daonil-hemi-daonil
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
glibenclamide
glyburide

---
http://www.lecrat.eu/?s=Glibenclamide+%3D+glyburide
2013
France
French
Glucovance
drug information
glyburide
glibenclamide
pregnancy
drug combinations
metformin and sulfonylureas
administration, oral
hypoglycemic agents
diabetes mellitus, type 2
metformin
breast feeding

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64369533
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61415185
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60026957
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63079915
2012
France
summary of product characteristics
package leaflet
metformin
tablets
glyburide
Glucovance

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68505991
2012
France
summary of product characteristics
package leaflet
Glucovance
tablets
metformin
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69206223
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62227581
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63264650
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64922382
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60497140
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61972152
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68151222
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65433693
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66586208
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69352192
2012
France
summary of product characteristics
package leaflet
glyburide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65515432
2012
France
summary of product characteristics
package leaflet
tablets
glyburide

---
http://www.has-sante.fr/portail/jcms/c_1332071/daonil-hemi-daonil
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/daonil_hemidaonil_17102012_avis_ct12426.pdf
http://www.has-sante.fr/portail/jcms/c_618830/daonil-hemidaonil
2012
France
French
glyburide
hypoglycemic agents
administration, oral
glibenclamide
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1069330/glucovance-association-fixe-de-metformine-500-mg-et-glibenclamide-2-5-mg-ou-5-mg-antidiabetique-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1054871/glucovance
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/glucovance_-_ct-7012.pdf
2011
France
French
evaluation of the transparency committee
guidelines for drug use
Glucovance
drug combinations
administration, oral
glyburide
metformin
hypoglycemic agents
insurance, health, reimbursement
metformin and sulfonylureas
adult
diabetes mellitus, type 2
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1036315/glibenclamide-biogaran
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-03/glibenclamide_-_ct-9492.pdf
2011
France
French
glyburide
administration, oral
insurance, health, reimbursement
hypoglycemic agents
diabetes mellitus, type 2
glibenclamide
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400023
http://www.has-sante.fr/portail/jcms/c_1054871/glucovance
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/glucovance_-_ct-7012.pdf
2011
France
French
Glucovance
glyburide
drug combinations
metformin
hypoglycemic agents
adult
administration, oral
metformin and sulfonylureas
insurance, health, reimbursement
diabetes mellitus, type 2
treatment outcome
glyburide
metformin
evaluation of the transparency committee

---
https://www.jle.com/fr/revues/medecine/stv/e-docs/00/04/1F/CF/resume.md
2006
France
French
sulfonylurea compounds
glyburide
cardiovascular diseases
risk factors
journal article

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.